Search for: "Novartis Pharma AG "
Results 61 - 80
of 124
Sorted by Relevance
|
Sort by Date
16 Mar 2011, 3:50 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Mar 2011, 9:19 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
1 May 2009, 9:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Mar 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 May 2011, 12:33 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Nov 2010, 1:48 am
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No… [read post]
12 Apr 2011, 10:07 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Jun 2011, 4:56 am
General Big Pharma accepts differential pricing – FINALLY! [read post]
19 Jan 2010, 12:55 pm
On the innovator side, Glaxo and Novartis have settled the most. [read post]
22 Apr 2010, 3:51 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Oct 2018, 2:30 pm
First, the application to bring back Zelnorm was made by Sloan Pharma, which acquired the rights to Zelnorm from Novartis. [read post]
27 Jul 2011, 1:01 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Feb 2022, 4:27 am
The case before the Swedish courts Novartis AG (“Novartis”) filed a lawsuit against Abacus Medicine A/S (“Abacus”), claiming that Abacus infringed its trademarks by replacing the original package of certain parallel imported medicinal products. [read post]
13 Dec 2021, 12:49 am
The meaning of Article 3(c) with respect to combination products was referred to the CJEU in Novartis (C-354/19) (IPKat). [read post]
7 Dec 2018, 12:58 am
Only then did the French Patent Office grant the new SPC to Novartis Pharma AG with decision of 4 June 2018. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
25 Jun 2018, 3:49 am
Starting from 2009, when the Supreme Commercial Court restrained a generic drug for the first time (Novartis AG vs. [read post]
22 Jul 2010, 8:35 am
Ian Bryan, IP Counsel, GE Healthcare Vineet Kohli, Senior Patent Attorney, Merck John Beatty, Patent Procedures Management, European Patent Office Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA Lawrence Cullen, Deputy Director, IPO Dr Scott Alban, Head of IP, MedImmune Allen Norris, Vice President, Head Group IP, UCB Pharma SA Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG … [read post]
30 Aug 2009, 10:00 pm
Bivins (a citizen of Texas) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. [read post]
5 Sep 2023, 2:39 am
Cir. 2007) and Novartis AG v. [read post]
